Millennium Laboratories Announces Genetic Pain Management Test

Millennium Laboratories has announced a pharmacogenetic test to help physicians prescribe opioids more effectively.

Advertisement

The test screens for genetic variations in enzymes that influences how the patient’s metabolism will process opioids. Physicians can use this information to adjust dosages and predict side effects.

More Articles on Pain Management:

Georgia’s Houston Medical Center May Expand Pain Clinic

DEA Schedules September National Prescription Drug Take-Back Day

New York Pain Consultants Partner With Medtronic on Physician Training

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.